Originally published in our sister publication, Pain Medicine News.
A crossover trial has found that open-label placebo (OLP) significantly reduced pain and the use of rescue medications for pain in children and adolescents with functional abdominal pain or irritable bowel syndrome (JAMA Pediatr 2022 Jan 31. doi:10.1001/jamapediatrics.2021.5750).
“There is evidence that the placebo effect is very powerful for disorders of gut–brain interaction,” said principal